Entera Bio to Host Webinar on Osteoporosis Treatment

Entera Bio will host a Key Opinion Leader webinar focusing on the osteoporosis treatment landscape and the potential of its drug candidate, EB613. The event aims to provide insights into current therapeutic approaches and highlight the opportunities for EB613 in addressing unmet needs in osteoporosis management. This webinar is crucial for disseminating information to healthcare professionals and investors about the company's research and development pipeline. It underscores Entera Bio's commitment to advancing osteoporosis treatments.